• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨质疏松症和骨折风险的遗传结构。

The genetic architecture of osteoporosis and fracture risk.

机构信息

Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, Netherlands.

Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, Netherlands.

出版信息

Bone. 2019 Sep;126:2-10. doi: 10.1016/j.bone.2019.04.005. Epub 2019 Apr 10.

DOI:10.1016/j.bone.2019.04.005
PMID:30980960
Abstract

Osteoporosis and fracture risk are common complex diseases, caused by an interaction of numerous disease susceptibility genes and environmental factors. With the advances in genomic technologies, large-scale genome-wide association studies (GWAS) have been performed which have broadened our understanding of the genetic architecture and biological mechanisms of complex disease. Currently, more than ~90 loci have been found associated with DXA derived bone mineral density (BMD), over ~500 loci with heel estimated BMD and several others with other less widely available bone parameters such as bone geometry, shape, and microarchitecture. Notably, several of the pathways identified by the GWAS efforts correspond to pathways that are currently targeted for the treatment of osteoporosis. Overall, tremendous progress in the field of the genetics of osteoporosis has been achieved with the discovery of WNT16, EN1, DAAM2, and GPC6 among others. Assessment of the function and biological mechanisms of the remaining genes may further untangle the complex genetic landscape of osteoporosis and fracture risk. With this review we aimed to provide a general overview of the existing GWAS studies on osteoporosis traits and fracture risk.

摘要

骨质疏松症和骨折风险是常见的复杂疾病,由许多疾病易感性基因和环境因素相互作用引起。随着基因组技术的进步,已经进行了大规模的全基因组关联研究(GWAS),这拓宽了我们对复杂疾病遗传结构和生物学机制的理解。目前,已经发现了90 多个与双能 X 线吸收法(DXA)测量的骨矿物质密度(BMD)相关的位点,超过500 个与足跟估计 BMD 相关的位点,还有一些与其他不太广泛可用的骨参数相关,如骨几何形状、形状和微观结构。值得注意的是,GWAS 研究中确定的几个途径与目前骨质疏松症治疗的靶点途径相对应。总的来说,随着 WNT16、EN1、DAAM2 和 GPC6 等基因的发现,骨质疏松症遗传学领域取得了巨大进展。评估其余基因的功能和生物学机制可能会进一步理清骨质疏松症和骨折风险的复杂遗传景观。通过这篇综述,我们旨在提供关于骨质疏松症特征和骨折风险的现有 GWAS 研究的概述。

相似文献

1
The genetic architecture of osteoporosis and fracture risk.骨质疏松症和骨折风险的遗传结构。
Bone. 2019 Sep;126:2-10. doi: 10.1016/j.bone.2019.04.005. Epub 2019 Apr 10.
2
Identifying Causes of Fracture Beyond Bone Mineral Density: Evidence From Human Genetics.确定骨密度以外导致骨折的原因:来自人类遗传学的证据。
J Bone Miner Res. 2022 Aug;37(8):1592-1602. doi: 10.1002/jbmr.4632. Epub 2022 Jun 28.
3
Increased detection of genetic loci associated with risk predictors of osteoporotic fracture using a pleiotropic cFDR method.使用多效性cFDR方法增加与骨质疏松性骨折风险预测因子相关的基因位点的检测。
Bone. 2017 Jun;99:62-68. doi: 10.1016/j.bone.2017.03.052. Epub 2017 Mar 31.
4
Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study.骨折风险的遗传和临床决定因素评估:全基因组关联研究和孟德尔随机化研究
BMJ. 2018 Aug 29;362:k3225. doi: 10.1136/bmj.k3225.
5
[Epidemiology of bone and joint disease - the present and future - . Molecular epidemiology of osteoporosis].[骨与关节疾病的流行病学——现状与未来——。骨质疏松症的分子流行病学]
Clin Calcium. 2014 May;24(5):685-93.
6
Integrating GWAS and Co-expression Network Data Identifies Bone Mineral Density Genes SPTBN1 and MARK3 and an Osteoblast Functional Module.整合 GWAS 和共表达网络数据鉴定出与骨密度相关的 SPTBN1 和 MARK3 基因以及成骨细胞功能模块。
Cell Syst. 2017 Jan 25;4(1):46-59.e4. doi: 10.1016/j.cels.2016.10.014. Epub 2016 Nov 17.
7
Are bone mineral density loci associated with hip osteoporotic fractures? A validation study on previously reported genome-wide association loci in a Chinese population.骨密度位点与髋部骨质疏松性骨折有关联吗?一项针对中国人群中先前报道的全基因组关联位点的验证研究。
Genet Mol Res. 2012 Jan 31;11(1):202-10. doi: 10.4238/2012.January.31.1.
8
Genetics of osteoporosis.骨质疏松症的遗传学。
Biochem Biophys Res Commun. 2014 Sep 19;452(2):287-93. doi: 10.1016/j.bbrc.2014.07.141. Epub 2014 Aug 16.
9
Twelve New Genomic Loci Associated With Bone Mineral Density.12 个与骨密度相关的新基因组位点。
Front Endocrinol (Lausanne). 2020 Apr 22;11:243. doi: 10.3389/fendo.2020.00243. eCollection 2020.
10
Insights into the genetics of osteoporosis from recent genome-wide association studies.从最近的全基因组关联研究中洞察骨质疏松症的遗传学。
Expert Rev Mol Med. 2011 Aug 26;13:e28. doi: 10.1017/S1462399411001980.

引用本文的文献

1
Family history of fracture and fracture risk: a meta-analysis to update the FRAX® risk assessment tool.骨折家族史与骨折风险:一项更新FRAX®风险评估工具的荟萃分析
Osteoporos Int. 2025 Aug 23. doi: 10.1007/s00198-025-07607-w.
2
Genetics and Vitamin D Interactions in Osteoporosis: A Path to Precision Medicine.骨质疏松症中的遗传学与维生素D相互作用:精准医学之路
J Cell Mol Med. 2025 Aug;29(16):e70780. doi: 10.1111/jcmm.70780.
3
Genetic Influences and Targeted Treatments in Osteoporosis: A Systematic Review.骨质疏松症的遗传影响与靶向治疗:一项系统评价
Cureus. 2025 Jul 7;17(7):e87436. doi: 10.7759/cureus.87436. eCollection 2025 Jul.
4
TNF receptor-associated factors: promising targets of natural products for the treatment of osteoporosis.肿瘤坏死因子受体相关因子:天然产物治疗骨质疏松症的潜在靶点
Front Physiol. 2025 May 27;16:1527814. doi: 10.3389/fphys.2025.1527814. eCollection 2025.
5
Nutraceuticals in osteoporosis prevention.用于预防骨质疏松症的营养保健品
Front Nutr. 2024 Oct 2;11:1445955. doi: 10.3389/fnut.2024.1445955. eCollection 2024.
6
Genome-wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemia.全基因组研究确定了与急性淋巴细胞白血病儿童骨毒性相关的新基因。
Br J Haematol. 2024 Nov;205(5):1889-1898. doi: 10.1111/bjh.19696. Epub 2024 Aug 14.
7
Association of rs4516035 Polymorphism with Osteoporosis in the Southeastern Iranian Population: A Case-Control Study.rs4516035 多态性与伊朗东南部人群骨质疏松症的关联:一项病例对照研究。
J Res Health Sci. 2024 Mar 18;24(1):e00603. doi: 10.34172/jrhs.2024.138.
8
Prevalence of osteoporosis in the Iranian population: a systematic review and meta-analysis.伊朗人群骨质疏松症的患病率:一项系统评价与荟萃分析。
J Diabetes Metab Disord. 2023 Nov 30;23(1):229-237. doi: 10.1007/s40200-023-01352-9. eCollection 2024 Jun.
9
Genetic Evaluation for Monogenic Disorders of Low Bone Mass and Increased Bone Fragility: What Clinicians Need to Know.单基因低骨量和骨脆性增加疾病的遗传评估:临床医生需要了解的内容。
Curr Osteoporos Rep. 2024 Jun;22(3):308-317. doi: 10.1007/s11914-024-00870-6. Epub 2024 Apr 11.
10
Diagnosis and therapeutic approach to bone health in patients with hypopituitarism.垂体功能减退症患者的骨骼健康诊断和治疗方法。
Rev Endocr Metab Disord. 2024 Jun;25(3):513-539. doi: 10.1007/s11154-024-09878-w. Epub 2024 Apr 3.